+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke



Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke



Postgraduate Medicine 128(6): 620-628



Nonvalvular Atrial fibrillation (NVAF) is the most common cardiac arrhythmia associated with an increase in risk of stroke and systemic thromboembolism. Strokes related to AF are associated with higher mortality, greater disability, longer hospital stays, and lower chance of being discharged home. The present review will focus on the current status of detecting NVAF and stroke prevention when there is AF. The CHA2DS2-VASc risk stratification scheme is discussed for the identification of patients who are at risk for thromboembolic stroke related to NVAF. Patient with a CHA2DS2-VASc score of 2 or greater are candidates for warfarin or a novel oral anticoagulant, irrespective of whether the strategy is for rate or rhythm control. Finally, guidelines and landmark clinical trials in NVAF patients with primary or secondary stroke prevention are discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057585013

Download citation: RISBibTeXText

PMID: 27263867

DOI: 10.1080/00325481.2016.1195236


Related references

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy. Heart and Vessels 31(7): 1148-1153, 2017

Warfarin therapy for secondary prevention of cardioembolic stroke with nonvalvular atrial fibrillation--a retrospective study. Rinsho Shinkeigaku 33(8): 850-855, 1993

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke. International Journal of Cardiology 215: 11-13, 2017

Late recurrence of embolic stroke after discontinuation of anticoagulant therapy in nonvalvular atrial fibrillation. Journal of Neurology 235(8): 499-500, 1988

Comparison of prothromboembolic state and cardiac function between nonvalvular atrial fibrillation cases and atrial fibrillation cases with valvular heart disease in severe cardioembolic stroke. Stroke 30(1): 246, 1999

Nonvalvular atrial fibrillation associated with cardioembolic stroke: the role of hypertensive heart disease. Australian and New Zealand Journal of Medicine 20(2): 127-134, 1990

The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients. European Journal of Neurology 26(2): E24-E24, 2019

Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks. Stroke 37(1): 274-275, 2006

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks. Stroke 39(4): 1399-1400, 2008

Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases 27(11): 3155-3162, 2018

The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke. Journal of Stroke and Cerebrovascular Diseases 22(8): E343-E346, 2014

Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation. Stroke 26(8): 1365-1368, 1995

Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation. Journal of Stroke and Cerebrovascular Diseases 22(6): 846-850, 2014